Clinical trials
Completed Carotid Artery Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Boston Scientific Corporation | 2 |
| Medtronic Endovascular | 2 |
| Silk Road Medical | 2 |
| W.L.Gore & Associates | 2 |
| Aristotle University Of Thessaloniki | 1 |
| Artivion Inc. | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Columbia University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carotid Artery Diseases | 37 |
| Carotid Stenosis | 12 |
| Stroke | 12 |
| Vascular Diseases | 4 |
| Constriction, Pathologic | 3 |
| Peripheral Arterial Disease | 3 |
| Arterial Occlusive Diseases | 2 |
| Brain Diseases | 2 |
| Cardiovascular Diseases | 2 |
| Central Nervous System Diseases | 2 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.